Scientific Advisory Board
JHMRI’s Scientific Advisory Board reviews the Institute’s activities on a yearly basis, and provides recommendations on organizational, administrative and scientific matters.
Daniel Goldberg, MD, PhD
Professor of Medicine and Molecular Microbiology
He is also an investigator of the Howard Hughes Medical Institute. He served as Director of the Medical Scientist Training Program and currently serves as Co-chief of the Infectious Diseases Division. Dr. Goldberg studies the biochemistry of Plasmodium falciparum, focusing on proteolytic events responsible for hemoglobin degradation and host cell exit.
Diane Griffin, MD, PhD
Professor, Department of Molecular Microbiology and Immunology
She was the founding Director of the Johns Hopkins Malaria Research Institute. She holds joint appointments in Neurology and Medicine at JHSOM and is past President of the American Society for Virology, the Association of Medical School Microbiology Chairs and the American Society for Microbiology. In 2009, she was inducted into the Maryland Women's Hall of Fame. She currently serves as Vice President of the National Academy of Sciences. Dr. Griffin served as the Alfred and Jill Sommer Professor and Chair in the Department of Molecular Microbiology and Immunology from 1994 to 2015.
Thomas Kelly, MD, PhD
Benno C. Schmidt Chair of Cancer Research
Dr. Kelly is the Benno C. Schmidt Chair of Cancer Research, Member of Memorial Sloan Kettering Cancer Center, and Professor, Weill Graduate School of Biomedical Sciences, Cornell University. Until March 2013, he served as Director of the Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center. Previously he was the Boury Professor and Chairman of Molecular Biology and Genetics at the Johns Hopkins University School of Medicine. In 2000, he was Founding Director of the University's Institute for Basic Biomedical Sciences. He earned his MD and PhD from the Johns Hopkins University School of Medicine. Dr. Kelly's work has focused on how the genome is duplicated during the cell cycle, particularly the ways in which replication of DNA is initiated and controlled.
Sanjai Kumar, PhD
Chief, Laboratory of Emerging Pathogens
Dr. Kumar leads the Laboratory of Emerging Pathogens at the U.S. Food and Drug Administration and has been an Adjunct Investigator with the Laboratory of Malaria and Vector Research at the National Institute of Allergy and Infectious Diseases since 1996. He earned his Masters of Science in Zoology with a specialization in Parasitology at Lucknow University, India and his PhD in Microbiology at the Central Drug Research Institute in Lucknow, India. His major field of study is the molecular immunology and pathogenesis of malaria and Babesia.
Louis Miller, MD
Chief, Malaria Cell Biology Section
Dr. Miller received his B.S. from Haverford College, his M.S. from Columbia University, and his MD from Washington University in St. Louis. He served as a medical resident at Montifiore Hospital, New York, and as an intern and resident at Mount Sinai Hospital. He is a member of the Association of American Physicians, American Society of Clinical Investigation, American Society of Tropical Medicine and Hygiene, Royal Society of Tropical Medicine and Hygiene, National Academy of Sciences, and the Institute of Medicine. In 2011, he received the Walter Reed Medal for distinguished accomplishment in the field of tropical medicine from the American Society of Tropical Medicine and Hygiene.
Christopher Plowe, MD, MPH, FASTMH
Director, Duke Global Health Institute and Professor of Medicine and Global Health (Medicine/Infectious Diseases)
Dr. Plowe has directed the Duke Global Health Institute since 2018, after serving as the Frank M. Calia, MD Professor of Medicine and founding director of the Institute for Global Health at the University of Maryland. He received his MD degree from Cornell University Medical College and his MPH at the Columbia University School of Public Health. He completed his residency at St. Luke's Hospital in New York and his clinical infectious diseases fellowship at the Johns Hopkins School of Medicine. He is widely recognized for his research on the molecular epidemiology of drug-resistant and "vaccine-resistant" malaria.
Eric Schoomaker, MD, PhD, Lieutenant General, US Army (retired)
Scholar-in-Residence and Distinguished Professor
Eric Schoomaker, MD, PhD, Lieutenant General, US Army (retired) is Professor and Vice Chair for Leadership, Centers and Programs in Military & Emergency Medicine within the School of Medicine of the Uniformed Services University of the Health Sciences. General Schoomaker served as the 42nd Surgeon General of the US Army and Commanding General of the US Army Medical Command. He is an internist and hematologist who has led medical centers such as Walter Reed Army Medical Center; the US Army Medical Research & Materiel Command and Fort Detrick, MD; health regional commands; a community hospital and a multi-functional deployable medical brigade. His interests are in health & healthcare leadership, community well-being and comprehensive integrated pain management.
Alfred Sommer, MD, MHS
Professor of Epidemiology
He was Dean of the Johns Hopkins Bloomberg School of Public Health from 1990- 2005. His research interests include outcome assessments, child survival, epidemiology of visual disorders, glaucoma, vitamin A deficiency, blindness prevention strategies, cost-benefit analysis, the growing interface between medicine and public health and clinical guidelines.
Allan Spradling, PhD
Director, Department of Embryology
Dr. Spradling is the Director of the Department of Embryology at the Carnegie Institution of Washington in Baltimore, MD. He holds adjunct appointments in the Department of Biology and the Department of Molecular Biology and Genetics at the Johns Hopkins University and the Johns Hopkins Medical Institutes. Using Drosophila he studies the biology of reproduction. He is interested in stem cells, egg development, and new technology for understanding how genes control tissue development and function. His group investigates the basic biology of tissue stem cells and explores the parallels between germ cell development in Drosophila and mammals.
Kathryn Zoon, PhD
Director, Division of Intramural Research (DIR)
Dr. Zoon was previously Deputy Director for Planning and Development at DIR and she served as the Principal Deputy Director of the Center for Cancer Research at the National Cancer Institute. Before arriving at NIH, Dr. Zoon led the FDA’s Center for Biologics Evaluation and Research. In addition to serving as Associate Editor of the Journal of Interferon Research, Dr. Zoon also serves on the Board of Directors of the International Association for Biologicals. She earned her doctorate degree from Johns Hopkins University.